Management and Determining the Cause

Chief Complaint: Breast Mass

a. History: No Co-morbidties

b. Ultrasound: Solid Mass

Next Pivotal Assessment Finding

Mammography

Rationale

 

BI-RADS 3

BI-RADS 4

BI-RADS 5

 

The BI-RADS (Breast Imaging-Reporting and Data System) classification is a standardized system developed by the American College of Radiology (ACR) for interpreting and reporting breast imaging findings, including mammography, ultrasound, and MRI. It helps radiologists communicate findings clearly, assess the level of suspicion for breast cancer, and guide clinical management.

BI-RADS Categories:

  1. Category 0 – Incomplete: Additional imaging or prior studies needed.
  2. Category 1 – Negative: No abnormal findings; routine screening.
  3. Category 2 – Benign: Non-cancerous findings (e.g., cysts, fibroadenomas); routine screening.
  4. Category 3 – Probably Benign (≤2% risk): Follow-up imaging recommended in 6 months.
  5. Category 4 – Suspicious Abnormality (2-95% risk): Biopsy recommended.
    • 4A: Low suspicion (2-10%).
    • 4B: Moderate suspicion (10-50%).
    • 4C: High suspicion (50-95%).
  6. Category 5 – Highly Suggestive of Malignancy (>95% risk): Biopsy strongly recommended.
  7. Category 6 – Known Malignancy: Biopsy-proven cancer; treatment planned.

Clinical Implications

  • Categories 1 & 2 → Routine follow-up.
  • Category 3 → Short-term follow-up to ensure stability.
  • Categories 4 & 5 → Biopsy necessary.
  • Category 6 → Confirmed cancer, proceeding to treatment.

 

 

++++++++++++++++

 

2. Tissue Diagnosis

  • Core Needle Biopsy (CNB): Standard for diagnosing solid breast masses.
  • Fine-Needle Aspiration (FNA): Less preferred for solid masses but may be considered in frail patients.
  • Excisional Biopsy: Reserved for non-diagnostic CNB or patient preference.

3. Management Based on Pathology

  • Benign (e.g., fibroadenoma, papilloma, fat necrosis): Observation or excision if symptomatic.
  • Atypical Lesions (e.g., atypical ductal/lobular hyperplasia): Surgical excision and surveillance.
  • Malignant (e.g., invasive ductal/lobular carcinoma):
    • Surgical Options: Lumpectomy or mastectomy, depending on tumor size, location, and patient preference.
    • Adjuvant Therapy: Radiation, endocrine therapy, chemotherapy, or targeted therapy based on tumor biology (ER/PR/HER2 status).
    • Elderly Considerations: Treatment is individualized, balancing benefits vs. frailty, life expectancy, and comorbidities.

4. Considerations for Geriatric Patients

  • Functional Status & Life Expectancy: Aggressive treatment may not be appropriate for frail elderly patients.
  • Comorbidities: Cardiovascular disease, diabetes, or dementia may limit treatment options.
  • Shared Decision-Making: Engage patient and family in discussing risks, benefits, and goals of care.

Would you like guidance on specific treatment options for elderly breast cancer patients?

+++++++++++++++++++

 

 

Well-defined, anechoic with posterior acoustic enhancement → usually benign, no further intervention required unless symptomatic.

Management and Determining the Cause

Digital World Medical School
© 2025